Directors' Dealing

19th Dec 2007 16:01

AGI Therapeutics plc19 December 2007 AGI Therapeutics plc ("AGI" or the "Company") Directors' Dealing The Company was informed on 18 December 2007 that on 12 December 2007 Mr RonanLambe, non executive chairman of AGI, acquired 139,030 ordinary shares of €0.01each ("Ordinary Shares") in the share capital of the Company at an average priceof €1.36223 per Ordinary Share. Following this trade, Mr Ronan Lambe has aninterest in 1,435,855 Ordinary Shares representing approximately 2.13% of theCompany's issued share capital. Contact Information: David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254 This information is provided by RNS The company news service from the London Stock Exchange

---

Related Shares:

Potentially Ai